Bruker Introduces Beta-Lactamase Testing, New Productivity Software Modules, as well as MBT Pilot and MBT Galaxy Accessories for MALDI Biotyper
Business Wire - Mon May 12, 4:00AM CDT
At the 24th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), Bruker introduces new and expanded research-use only (RUO) capabilities for the MALDI Biotyper(TM) platform.
New MRI CryoProbe(TM) Delivers Highest Sensitivity in Rat Brain in vivo Imaging
Business Wire - Mon May 12, 4:00AM CDT
At the joint ISMRM-ESMRMB 2014 meeting, Bruker today announced a new Phased Array MRI CryoProbe(TM) for in vivo neuroimaging that delivers unparalleled access to rat brain microstructure and biochemistry, previously unresolvable in in vivo imaging of the rat. The sensitivity increase by up to a factor of 2.4 allows researchers to reduce imaging times by a factor of 5, or to increase spatial resolution.
Bruker Reports First Quarter 2014 Financial Results
Business Wire - Wed May 07, 3:01PM CDT
Bruker Corporation (NASDAQ: BRKR) today reported financial results for its first quarter ended March 31, 2014.
New director added to Good Start Genetics board
M2 - Tue Apr 29, 10:11AM CDT
Good Start Genetics, Inc. said it has appointed Charles F. Wagner, Jr. to its board of directors.
PerkinElmer Beats on Q1 Earnings - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Apr 25, 12:50PM CDT
PerkinElmer, Inc. (PKI) raised its forecast for adjusted earnings per share to the range of $2.42 to $2.46 from $2.40 to $2.45 for 2014.
SHAREHOLDER ALERT: The Law Firm of Levi & Korsinsky, LLP Launches an Investigation into Bruker Corporation Regarding Possible Breaches of Fiduciary Duty
PR Newswire - Thu Apr 24, 3:34PM CDT
Levi & Korsinsky, LLP is investigating Bruker Corporation (NasdaqGS: BRKR) in connection with possible claims of breaches of fiduciary duty by certain members of the board of directors of the Company.
MKS Instruments Beats on Q1 Earnings, Revs - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Apr 24, 8:20AM CDT
MKS Instruments, Inc. (MKSI) beats the Zacks Consensus Estimate for earnings and revenues in the first quarter of 2014.
Bruker Announces Date and Time of First Quarter 2014 Earnings Release and Webcast
Business Wire - Thu Apr 24, 6:02AM CDT
Bruker (NASDAQ: BRKR) today announced that it will disclose its first quarter 2014 financial results on Wednesday, May 7, 2014, at 4:00 p.m. Eastern Time. The Company will then host a conference call and webcast at 4:45 p.m. Eastern Time to discuss the results and current business trends.
At Analytica 2014, Bruker Continues to Introduce Important New Products for Life Science Research, Industrial and Applied Markets
Business Wire - Tue Apr 01, 3:00AM CDT
At Analytica 2014, Bruker (NASDAQ: BRKR) today announced new product introductions and enhancements for improved performance and customer experience in research, industrial and applied markets. These very latest innovations complement the wide range of product announcements that were just recently presented at Pittcon 2014 (www.bruker.com/news/pittcon/pr-pittcon-2014). Designed to increase sensitivity, improve specificity and maximize productivity, the new Bruker products introduced at Analytica 2014 include:
Bruker Announces the SkyScan(TM) 2211 Multiscale High-Resolution X-Ray Nanotomograph
Business Wire - Tue Apr 01, 3:00AM CDT
At Analytica 2014, Bruker (NASDAQ: BRKR) today introduced the SkyScan(TM) 2211, a new high-resolution X-ray nano-CT (computed tomography) system with the widest available range of object sizes and spatial resolutions. With the SkyScan 2211, for the first time one single instrument is capable of non-destructive scanning and 3D reconstruction of internal microstructures of large objects, as well as providing submicron resolution for small samples. This multiscale X-ray nanotomograph opens unique possibilities for 3D imaging and exact modeling of materials in a number of applications, such as oil and gas exploration, composite materials, fuel cells, and electronic assemblies.
Bruker Up 13.4% Since SmarTrend Uptrend Call (BRKR)
Comtex SmarTrend(R) - Thu Mar 20, 5:05PM CDT
SmarTrend identified an Uptrend for Bruker (NASDAQ:BRKR) on January 16th, 2014 at $21.06. In approximately 2 months, Bruker has returned 13.42% as of today's recent price of $23.88.
Bruker Has Returned 12.9% Since SmarTrend Recommendation (BRKR)
Comtex SmarTrend(R) - Thu Mar 06, 10:03AM CST
SmarTrend identified an Uptrend for Bruker (NASDAQ:BRKR) on January 16th, 2014 at $21.06. In approximately 2 months, Bruker has returned 12.89% as of today's recent price of $23.77.
At Pittcon 2014, Bruker Introduces Numerous New and Enhanced Customer-Driven Products for Life-Science Research, Industrial and Applied Markets
Business Wire - Tue Mar 04, 6:00AM CST
At Pittcon 2014, Bruker (NASDAQ: BRKR) today announced new product introductions and enhancements for improved performance and customer experience in research, industrial and applied markets. Designed to increase sensitivity, improve specificity and maximize productivity, the new Bruker products introduced at Pittcon 2014 include:
Bruker Introduces S2 KODIAK(TM), the World's Most Advanced Online XRF Multi-Element Analyzer for Real-Time Results in Mining of Base Metal Ores and Industrial Minerals
Business Wire - Mon Feb 24, 12:05PM CST
At the 2014 Annual Society of Mining, Metallurgy and Exploration (SME) Meeting, Bruker (NASDAQ: BRKR) today announced the new online multi-element analyzer S2 KODIAK(TM). This new tool uses X-ray fluorescence spectrometry to analyze the elemental concentrations in ores and other materials on conveyor belts in real time. Since information about the ore grade becomes immediately available with the S2 KODIAK, mineral beneficiation and ore blending can be optimized. This allows substantially higher product grades, better cost efficiency, and increased mine output. Based on S2 KODIAK results, miners and plant operators are able to instantly adjust process parameters and achieve higher recoveries without time consuming and costly sample preparation. There are no delays waiting for results from an off-site laboratory.
Can Bruker (BRKR) Continue to Rise? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Feb 20, 7:56AM CST
Can Bruker (BRKR) Continue to Rise?
Hotels.com celebrates 10 million Welcome Rewards members
CNW Group - Thu Feb 20, 7:45AM CST
More than one million free nights awarded to members
Bruker Earnings Beat Drives Stock To 12-Year High
at Investor's Business Daily - Wed Feb 19, 10:54AM CST
High-tech instrument maker Bruker (BRKR) got a few price-target hikes Wednesday after it beat analysts' estimates late Tuesday, sending Bruker stock to a 12-year high on the stock market today. Bruker's Q4 earnings rose 11% over the year-earlier...
Bruker Reports Fourth Quarter and Full Year 2013 Financial Results
Business Wire - Tue Feb 18, 3:01PM CST
Bruker Corporation (NASDAQ: BRKR) today reported financial results for its fourth quarter and full year ended December 31, 2013.
Mettler-Toledo Jumps After Q4 Earnings Beat
at Investor's Business Daily - Thu Feb 06, 12:10PM CST
Precision-instrument maker Mettler-Toledo International (MTD) got a bullish response from Wall Street after it beat Q4 expectations late Wednesday, sending shares up more than 5% on the stock market today. Mettler-Toledo's Q4 profit rose 10% over the...